Withdrawn ID: | w129 |
---|---|
Canonical SMILES: | |
Standard InChI: | |
Standard InChIKey: | |
ATC class(es): | C10AA06 |
Molecular Formula: | C26H34FNO5 |
Molweight: | 459.55 |
Withdrawn due to drug safety reasons: | Yes |
---|---|
First approved: | 1997 |
First death: | 1998 |
First withdrawn: | 2001 |
Last withdrawn: | 2001 |
Reference: | https://www.ncbi.nlm.nih.gov/pubmed/15582059 |
Total reported cases (submitted by medical professionals) with Cerivastatin as primary suspect: | 5 |
---|
Life-Threatening condition: | 1 |
---|---|
Hospitalization (initial or prolonged): | 1 |
Disability: | 1 |
Side-effect | Case number |
---|---|
MUSCLE SPASMS | 2 |
MALAISE | 1 |
ARTHRALGIA | 1 |
BLOOD DISORDER | 1 |
BLOOD PRESSURE DIASTOLIC INCREASED | 1 |
CHROMATURIA | 1 |
COAGULOPATHY | 1 |
CONDITION AGGRAVATED | 1 |
HEPATIC FIBROSIS | 1 |
HYPERTENSION | 1 |
JAUNDICE | 1 |
LABORATORY TEST ABNORMAL | 1 |
LIVER DISORDER | 1 |
UNEVALUABLE EVENT | 1 |
MENTAL STATUS CHANGES | 1 |
MUSCLE DISORDER | 1 |
MUSCULAR WEAKNESS | 1 |
ORAL PAIN | 1 |
PAIN IN EXTREMITY | 1 |
POISONING | 1 |
RASH | 1 |
RENAL DISORDER | 1 |
RHABDOMYOLYSIS | 1 |
TOOTH FRACTURE | 1 |
Target UniProtKB ID | Activity in nm | Target Name | Target gene |
---|---|---|---|
P04035 | 10 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | HMDH_HUMAN |
Toxicity class: | 4 |
---|---|
Toxicity type: | muscular |
LD50: | 416 mg/kg |
ChEBML: | CHEMBL1477 |
---|---|
DrugBank: | DB00439 |